Polyhydroxylated Fullerene C60(OH)40 Nanofilms Promote the Mesenchymal–Epithelial Transition of Human Liver Cancer Cells via the TGF-β1/Smad Pathway
Open Access
- 1 August 2023
- journal article
- research article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 16, 3739-3761
Abstract
Background: The various growth factors change the phenotype of neoplastic cells from sedentary (epithelial) to invasive (mesenchymal), which weaken intercellular connections and promote chemotaxis. It can be assumed that the use of anti-inflammatory polyhydroxyfull nanofilms will restore the sedentary phenotype of neoplastic cells in the primary site of the tumor and, consequently, increase the effectiveness of the therapy. Methods: The studies were carried out on liver cancer cells HepG2, C3A and SNU-449, and non-cancer hepatic cell line THLE-3. Transforming growth factor (TGF), epidermal growth factor and tumor necrosis factor were used to induce the epithelial–mesenchymal transition. C60(OH)40 nanofilm was used to induce the mesenchymal–epithelial transition. Obtaining an invasive phenotype was confirmed on the basis of changes in the morphology using inverted light microscopy. RT-PCR was used to confirm mesenchymal or epithelial phenotype based on e-cadherin, snail, vimentin expression or others. Water colloids at a concentration of 100 mg/L were used to create nanofilms of fullerene, fullerenol, diamond and graphene oxide. The ELISA test for the determination of TGF expression and growth factor antibody array were used to select the most anti-inflammatory carbon nanofilm. Mitochondrial activity and proliferation of cells were measured by XTT and BrdU tests. Results: Cells lost their natural morphology of cells growing in clusters and resembled fibroblast cells after adding a cocktail of factors. Among the four allotropic forms of carbon tested, only the C60(OH)40 nanofilm inhibited the secretion of TGF in all the cell lines used and inhibited the secretion of other factors, including insulin-like growth factor system. Nanofilm C60(OH)40 was non-toxic to liver cells and inhibited the TGF-β 1/Smad pathway of invasive cells treated with the growth factor cocktail. Conclusion: The introduction of an anti-inflammatory, nontoxic component that can induce the mesenchymal–epithelial transition of cancer cells may represent a future adjuvant therapy after tumor resection. Graphical Abstract:Keywords
This publication has 60 references indexed in Scilit:
- Cytotoxic Effects of Hydroxylated Fullerenes in Three Types of Liver CellsMaterials, 2013
- Ectopic Expression of MiR-125a Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma by Targeting MMP11 and VEGFPLOS ONE, 2012
- Anoikis Resistance: An Essential Prerequisite for Tumor MetastasisInternational Journal of Cell Biology, 2012
- Immune Promotion of Epithelial-mesenchymal Transition and Generation of Breast Cancer Stem CellsCancer Research, 2010
- Tumor necrosis factor-α enhances both epithelial-mesenchymal transition and cell contraction induced in A549 human alveolar epithelial cells by transforming growth factor-β1Experimental Lung Research, 2010
- Epithelial‐to‐mesenchymal transitions in the liver†Hepatology, 2009
- Mechanisms of the Epithelial–Mesenchymal Transition by TGF-βFuture Oncology, 2009
- Twist Overexpression Correlates with Hepatocellular Carcinoma Metastasis through Induction of Epithelial-Mesenchymal TransitionClinical Cancer Research, 2006
- Multihydroxylated [Gd@C82(OH)22]n Nanoparticles: Antineoplastic Activity of High Efficiency and Low ToxicityNano Letters, 2005
- The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expressionNature Cell Biology, 2000